Literature DB >> 25166299

Hemolytic anemia and metabolic acidosis: think about glutathione synthetase deficiency.

Salma Ben Ameur1, Hajer Aloulou, Fehmi Nasrallah, Thouraya Kamoun, Naziha Kaabachi, Mongia Hachicha.   

Abstract

Glutathione synthetase deficiency (GSSD) is a rare disorder of glutathione metabolism with varying clinical severity. Patients may present with hemolytic anemia alone or together with acidosis and central nervous system impairment. Diagnosis is made by clinical presentation and detection of elevated concentrations of 5-oxoproline in urine and low glutathione synthetase activity in erythrocytes or cultured skin fibroblasts. The prognosis seems to depend on early diagnosis and treatment. We report a 4 months old Tunisian male infant who presented with severe metabolic acidosis with high anion gap and hemolytic anemia. High level of 5-oxoproline was detected in her urine and diagnosis of GSSD was made. Treatment consists of the correction of acidosis, blood transfusion, and supplementation with antioxidants. He died of severe metabolic acidosis and sepsis at the age of 15 months.

Entities:  

Keywords:  gluthatione synthetase; hemolytic anemia; metabolic acidosis

Mesh:

Substances:

Year:  2014        PMID: 25166299     DOI: 10.3109/15513815.2014.947543

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  3 in total

1.  Amniotic fluid metabolomic and lipidomic alterations associated with hemoglobin Bart's diseases.

Authors:  Xiaohang Chen; Hongyan Chen; Haimei Nie; Gaochi Li; Jinjiang Su; Xianzhen Cao; Yongli Cao; Fengxiang Wei
Journal:  Metabolomics       Date:  2021-09-06       Impact factor: 4.290

2.  Nineteen-year follow-up of a patient with severe glutathione synthetase deficiency.

Authors:  Paldeep S Atwal; Casey R Medina; Lindsay C Burrage; V Reid Sutton
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

3.  A case of severe glutathione synthetase deficiency with novel GSS mutations.

Authors:  H Xia; J Ye; L Wang; J Zhu; Z He
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.